Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Capital Reinvestment Ratio

Latest as of September 2025: 0.00x

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($137.91K) in capital expenditures ($4.00). See how much free cash does Drugs Made In America Acquisition Corp. generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$137.91K
USD

Capital Expenditures

$4.00
USD

Data as of

Sep 2025
Most recent filing

Annual Capital Reinvestment Ratio for Drugs Made In America Acquisition Corp. Ordinary Shares (None–None)

Year-by-year Capital Reinvestment Ratio for Drugs Made In America Acquisition Corp. Ordinary Shares from None to None. For live market cap and broader valuation context, see Drugs Made In America Acquisition Corp. stock valuation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow